LASP Antibodies

Santa Cruz Biotechnology features a diverse variety of LASP Antibodies for investigating the role of LIM and SH3 protein (LASP) in cellular processes. Monoclonal LASP Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LASP is a cytoskeletal protein essential for cell adhesion, migration, and signaling pathways, making it particularly relevant in cancer research and developmental biology. The regulation of actin dynamics by LASP and its interaction with other signaling molecules highlights its significance in maintaining cellular integrity and function. Research has shown that LASP expression levels often correlate with cancer progression and patient outcomes. Understanding LASP's molecular mechanisms provides valuable insights into tumor progression and metastasis. Investigating LASP's role in different tissue types can reveal new therapeutic targets for cancer treatment. Santa Cruz Biotechnology monoclonal LASP Antibodies enable researchers to advance scientific understanding of cellular processes and potential therapeutic applications.